Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1170 of 5804
-
New Weight-Loss drug combo tested in early trial
Disease control Recruiting nowStudy to assess the safety, pharmacokinetics (the amount of study drug or any of its breakdown products in your body) and pharmacodynamics (how the study drug affects your body) of RN3161 alone (healthy volunteers) and RN3161 with tirzepatide (overweight and obese subjects)
Phase: PHASE1, PHASE2 • Sponsor: Ikaria Bioscience Pty Ltd • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New program aims to curb stimulant use and HIV spread among teens and young adults
Disease control Recruiting nowThe use of behavioral intervention to reduce stimulant use and concurrent HIV sexual transmission risk.
Phase: NA • Sponsor: Westat • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New study aims to help vulnerable canadians quit smoking with nicotine spray and cytisine
Disease control ENROLLING_BY_INVITATIONTobacco is the most preventable cause of disease and death in Canada. Although the tobacco use rate has substantially gone down in the general population, significant differences exist between sub-populations in Canada, for example Ottawa's highly vulnerable homeless or at-risk f…
Phase: NA • Sponsor: Ottawa Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Could one hour replace two days? new trial aims to speed up cancer care
Symptom relief Recruiting nowThe goal of this clinical trial is to understand whether the Magnetic Resonance Linear Accelerator (MRL) could expedite Radiotherapy treatment for Metastatic Cord Compression (MSCC) by removing the need for a planning CT (pCT) scan prior to treatment. Radiotherapy will be deliver…
Phase: NA • Sponsor: The Christie NHS Foundation Trust • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
New hope for Still's disease: experimental drug enters Mid-Stage trial
Disease control Recruiting nowThe study is a phase II trial designed to evaluate the clinical efficacy, safety, and tolerability of MAS825 (arumakimig) in pediatric and adult participants with Still's disease
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New nasal COVID vaccine could replace shots
⭐️ VACCINE ⭐️ OngoingA Double-blind, Randomized, Controlled, Phase 2a Study to Evaluate the Safety and Tolerability of a Newcastle Disease Virus-based Mucosal Vaccine (NDV-HXP-S-KP.2) Relative to an Approved Systemic mRNA Vaccine in Previously Vaccinated Adults
Phase: PHASE2 • Sponsor: CastleVax Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 24, 2026 00:00 UTC
-
CBD boosts talk therapy for anxiety? new trial investigates
Symptom relief Recruiting nowThis randomized, double-blind, placebo-controlled clinical trial investigates the use of Food and Drug Administration (FDA)-approved cannabidiol (EPIDIOLEX®) as an adjunct to cognitive behavioral therapy (CBT) in adults with generalized anxiety disorder (GAD). The study aims to e…
Phase: PHASE3 • Sponsor: Wayne State University • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
New pain drug could cut opioid use after hip surgery
Symptom relief Recruiting nowTotal hip and knee joint replacements are among the most common and painful orthopedic procedures performed worldwide, often requiring intensive analgesia to support early ambulation and recovery. Despite widespread use of multimodal regimens, many patients still rely on opioids,…
Phase: PHASE3 • Sponsor: Hospital for Special Surgery, New York • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Can a new pill bring back skin color in vitiligo?
Disease control Recruiting nowVitiligo is a long-term autoimmune condition that causes the skin to lose its color. The body's germ-fighting system (immune system) mistakenly attacks the skin cells (melanocytes) which produce the pigment that gives the skin color (melanin). This leads to the formation of patch…
Phase: PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Engineered immune cells target stubborn abdominal cancer
Disease control Recruiting nowThis single-arm, open-label, dose-escalation trial aims to evaluate the safety and efficacy of CEA-targeted CAR-T cells and to obtain their pharmacokinetic profile in patients with advanced colorectal cancer and peritoneal metastases after cytoreductive surgery; the recommended d…
Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New scan could spare men unnecessary biopsies
Diagnosis Recruiting nowThe goal of this clinical study is to test the performance of PSMA PET/MRI-guided biopsies against systematic biopsies in men with negative MRI scan (PI-RADS 1-2) of the prostate with continuous suspicion of clinically significant prostate cancer (csPCa) due to PSAd \> 0.20. The …
Phase: NA • Sponsor: Mads Ryo Jochumsen • Aim: Diagnosis
Last updated Jun 27, 2026 08:01 UTC
-
New drug shows promise for dangerous virus in blood cancer patients
Disease control Recruiting nowThis is an open-label, single arm, multicenter study to evaluate the feasibility of maribavir treatment in multiple myeloma and lymphoma patients undergoing bispecific antibody treatment and experiencing treatment emergent CMV events
Phase: PHASE2 • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Smart system aims to boost cholesterol control in stroke survivors
Disease control Recruiting nowThis study will conduct a cluster randomized controlled trial to Evaluate whether the Intelligent Lipid Management Decision-support System can increase the proportion of patients 1-year target achievement (\<1.8 mmol/L) in acute ischemic stroke or TIA patients under Evolocumab tr…
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New drug may stop bleeding after heart surgery better than standard care
Disease control Recruiting nowCoagulopathic-induced bleeding after cardiopulmonary bypass in cardiac surgery patients is common and is associated with adverse outcomes in cardiac surgery. The hypothesis of the study is that FEIBA will be a more effective treatment than standard of care (FFP) in cardiac surger…
Phase: PHASE2 • Sponsor: Northwell Health • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New combo pill aims to boost cystic fibrosis treatment
Disease control OngoingThe purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of SION-719 when given to people with CF who are already taking Trikafta.
Phase: PHASE2 • Sponsor: Sionna Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could a few drops of milk boost preemie brain and feeding?
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if the multisensory early oral administration of human milk (M-MILK) intervention helps infants who are born younger than 32 weeks gestational age (very preterm infants). The main question that this clinical trial aims to answer is: Doe…
Phase: NA • Sponsor: Loyola University • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Feeding or fasting? study probes transfusion risks in tiny preemies
Knowledge-focused Recruiting nowMAGPIE-2 is a prospective observational study designed to investigate the physiological mechanisms linking blood transfusion and enteral feeding practices to gut perfusion and oxygenation in very preterm infants. The study is nested within the WHEAT International randomised contr…
Sponsor: Imperial College Healthcare NHS Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
Exercise program aims to fight 'Chemo Brain' in Long-Term survivors
Disease control Not yet recruitingStudy Rationale: Breast cancer survivors are more likely to develop cardiovascular disease (CVD) or neurocognitive disease than age-matched counterparts without a history of cancer diagnosis. Some anti-cancer treatments cause damage to the cells of heart and the walls of blood v…
Phase: NA • Sponsor: Baker Heart and Diabetes Institute • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Texts and calls could be key to beating high blood pressure in nepal
Disease control Recruiting nowDespite evidence of preventing cardiovascular disease (CVD) risk through lifestyle changes, many patients with hypertension (HTN) do not comply with this and suffer from CVD and other complications. A previous study using a structured lifestyle intervention program has reported a…
Phase: NA • Sponsor: Central Department of Public Health • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Could a milk protein help dialysis patients fight anemia?
Disease control OngoingThe aim of this interventional study is to assess the effectiveness of oral lactoferrin in improving hemoglobin levels and correcting iron deficiency anemia in patients with end-stage renal disease (ESRD) on dialysis and also evaluate the impact of lactoferrin on bone health by m…
Phase: PHASE2 • Sponsor: Beni-Suef University • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC